Your browser doesn't support javascript.
loading
A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.
Rodríguez-Gallego, Esther; Gómez, Josep; Pacheco, Yolanda M; Peraire, Joaquim; Viladés, Consuelo; Beltrán-Debón, Raúl; Mallol, Roger; López-Dupla, Miguel; Veloso, Sergi; Alba, Verónica; Blanco, Julià; Cañellas, Nicolau; Rull, Anna; Leal, Manuel; Correig, Xavier; Domingo, Pere; Vidal, Francesc.
Afiliação
  • Rodríguez-Gallego E; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Gómez J; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Pacheco YM; Department of Electronic Engineering, Metabolomics Platform, Rovira i Virgili University, IISPV, Tarragona.
  • Peraire J; Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville.
  • Viladés C; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Beltrán-Debón R; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Mallol R; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • López-Dupla M; Department of Electronic Engineering, Metabolomics Platform, Rovira i Virgili University, IISPV, Tarragona.
  • Veloso S; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Alba V; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Blanco J; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Cañellas N; AIDS Research Institute IrsiCaixa, Institut Germans Trias I Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona.
  • Rull A; Universitat de Vic-Universitat Central de Catalunya, Vic.
  • Leal M; Department of Electronic Engineering, Metabolomics Platform, Rovira i Virgili University, IISPV, Tarragona.
  • Correig X; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid.
  • Domingo P; HIV Unit, Department of Internal Medicine and Infectious Diseases, Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili.
  • Vidal F; Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, IBiS, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville.
AIDS ; 32(5): 565-573, 2018 03 13.
Article em En | MEDLINE | ID: mdl-29280761
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Antirretrovirais / Metaboloma Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Antirretrovirais / Metaboloma Idioma: En Ano de publicação: 2018 Tipo de documento: Article